Global Cold Pain Therapy Market Size study, By Product (OTC Products, Prescription Products), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, E- Pharmacies), By Application (Musculoskeletal Disorders, Post-operative Therapy, Sports Injuri

Global Cold Pain Therapy Market Size study, By Product (OTC Products, Prescription Products), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, E- Pharmacies), By Application (Musculoskeletal Disorders, Post-operative Therapy, Sports Injuries, Post-trauma Therapy), and Regional Forecasts 2022-2028

Global Cold Pain Therapy Market is valued at approximately USD XX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2028. Cold pain therapy also commonly known as cryotherapy is performed to reduce pain and swelling that has been the source of pain. This therapy temporarily decreases nerve signals, which helps in lessening pain. Factors such as rising incidences of sports injuries, the growing frequency of hip and knee surgeries, increasing geriatric population, coupled with the rise in bone diseases and trauma injuries are impelling the growth of the global market. For instance, as per the National Library of Medicine, it is estimated that every year nearly 1.5 million people suffer a fracture because of some bone disease. Consequentially, the growing occurrence of bone disease is witnessing higher demand for Cold Pain Therapy, which stimulates the market growth around the world. However, the lack of substantial clinical evidence and reimbursement in favor of cold pain therapy and the availability of alternative non-drug/device pain management therapies impede the growth of the market over the forecast period of 2022-2028. Also, the increasing demand for analgesic patches and the growing requirement for safer pain management modalities as opposed to oral drug therapy are anticipated to act as catalyzing factors for the market demand during the forecast period.

The key regions considered for the global Cold Pain Therapy Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the availability of skilled professionals and increasing healthcare expenditure. Whereas, Asia-Pacific is anticipated to exhibit the highest CAGR over the forecast period 2022-2028. Factors such as the increasing aging population, as well as, growing incidences of orthopedic diseases, would create lucrative growth prospects for the Cold Pain Therapy Market across the Asia-Pacific region.

Major market players included in this report are:
Beiersdorf AG
DJO Global, Inc.
Hisamitsu Pharmaceutical Co., Inc.
Johnson & Johnson
Pfizer
Sanofi
Rohto Pharmaceutical
3M
Cardinal Health Inc.
Breg, Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
OTC Products
Prescription Products
By Distribution Channel:
Retail Pharmacies
Hospital Pharmacies
E- Pharmacies
By Application:
Musculoskeletal Disorders
Post-operative Therapy
Sports Injuries
Post-trauma Therapy
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028

Target Audience of the Global Cold Pain Therapy Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Companies Mentioned

Beiersdorf AG
DJO Global, Inc.
Hisamitsu Pharmaceutical Co., Inc.
Johnson & Johnson
Pfizer
Sanofi
Rohto Pharmaceutical
3M
Cardinal Health Inc.
Breg, Inc.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.